Lipopolysaccharide administration in vivo induces differential expression of cAMP-specific phosphodiesterase 4B mRNA splice variants in the mouse brain

Journal of Neuroscience Research

Volumn 89, Issue 11, 2011, Pages 1761-1772

  Johansson, Emily M ^a   Sanabra, Cristina ^a   Cortés, Roser ^a   Vilaró, M Teresa ^a   Mengod, Guadalupe ^a  

^a INST D INVESTIGACIONS B   (Spain)

Author keywords

Anatomy; COX; In situ hybridization; Neuroinflammation; TNF

Indexed keywords

CYCLIC AMP; LIPOPOLYSACCHARIDE; MESSENGER RNA; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE IVB; PHOSPHODIESTERASE IVB2; PHOSPHODIESTERASE IVB3; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENCEPHALITIS; ENDOTHELIUM CELL; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMUNE RESPONSE; IN VIVO STUDY; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ANIMALS; BRAIN; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; LECTINS; LIPOPOLYSACCHARIDES; MALE; MICE; PROTEIN ISOFORMS; RNA, MESSENGER;

EID: 80052646440     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22707     Document Type: Article

References (56)

1. Ahmed T, Frey JU. 2003. Expression of the specific type IV phosphodiesterase gene PDE4B3 during different phases of long-term potentiation in single hippocampal slices of rats in vitro. Neuroscience 117: 627-638.
2. Arp J, Kirchhof MG, Baroja ML, Nazarian SH, Chau TA, Strathdee CA, Ball EH, Madrenas J. 2003. Regulation of T-cell activation by phosphodiesterase 4B2 requires its dynamic redistribution during immunological synapse formation. Mol Cell Biol 23: 8042-8057.
3. Banner KH, Trevethick MA. 2004. PDE4 inhibition: a novel approach for the treatment of inflammatory bowel disease. Trends Pharmacol Sci 25: 430-436.
4. Bender AT, Beavo JA. 2006. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 58: 488-520.
5. Boswell-Smith V, Spina D, Page CP. 2006. Phosphodiesterase inhibitors. Br J Pharmacol 147: S252-S257.
6. Breder CD, Saper CB. 1996. Expression of inducible cyclooxygenase mRNA in the mouse brain after systemic administration of bacterial lipopolysaccharide. Brain Res 713: 64-69.
7. Breder CD, Hazuka C, Ghayur T, Klug C, Huginin M, Yasuda K, Teng M, Saper CB. 1994. Regional induction of tumor-necrosis-factor alpha expression in the mouse-brain after systemic lipopolysaccharide administration. Proc Natl Acad Sci U S A 91: 11393-11397.
8. Buljevac D, Flach HZ, Hop WC, Hijdra D, Laman JD, Savelkoul HF, Der Meche FG, van Doorn PA, Hintzen RQ. 2002. Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain 125: 952-960.
9. Cai Z, Pang Y, Lin S, Rhodes PG. 2003. Differential roles of tumor necrosis factor-alpha and interleukin-1 beta in lipopolysaccharide-induced brain injury in the neonatal rat. Brain Res 975: 37-47.
10. Cherry JA, Davis RL. 1999. Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement, and affect. J Comp Neurol 407: 287-301.
11. Conti M. 2000. Phosphodiesterases and cyclic nucleotide signaling in endocrine cells. Mol Endocrinol 14: 1317-1327.
12. Conti M, Beavo J. 2007. Biochemistry and physiology of cyclic nucleotide Phosphocliesterases: Essential components in cyclic nucleotide signaling. Annu Rev Biochem 76: 481-511.
13. D'sa C, Tolbert LM, Conti M, Duman RS. 2002. Regulation of cAMP-specific phosphodiesterases type 4B and 4D (PDE4) splice variants by cAMP signaling in primary cortical neurons. J Neurochem 81: 745-757.
14. D'souza SD, Alinauskas KA, Antel JP. 1996. Ciliary neurotrophic factor selectively protects human oligodendrocytes from tumor necrosis factor-mediated injury. J Neurosci Res 43: 289-298.
15. Elmquist JK, Breder CD, Sherin JE, Scammell TE, Hickey WF, Dewitt D, Saper CB. 1997. Intravenous lipopolysaccharide induces cyclooxygenase 2-like immunoreactivity in rat brain perivascular microglia and meningeal macrophages. J Comp Neurol 381: 119-129.
16. Franklin KBJ, Paxinos G. 2007. The mouse brain in stereotaxic coordinates. New York: Academic Press.
17. Goppelt-Struebe M. 1995. Regulation of prostaglandin endoperoxide synthase (cyclooxygenase) isozyme expression. Prostaglandins Leukot Essent Fatty Acids 52: 213-222.
18. Graeber MB, Streit WJ. 1990. Perivascular microglia defined. Trends Neurosci 13: 366.
19. Hart BL. 1988. Biological basis of the behavior of sick animals. Neurosci Biobehav Rev 12: 123-137.
20. Hebenstreit GF, Fellerer K, Fichte K, Fischer G, Geyer N, Meya U, Hernandez M, Schony W, Schratzer M, Soukop W. 1989. Rolipram in major depressive disorder: results of a double-blind comparative study with imipramine. Pharmacopsychiatry 22: 156-160.
21. Houslay MD. 1998. Adaptation in cyclic AMP signalling processes: a central role for cyclic AMP phosphodiesterases. Semin Cell Dev Biol 9: 161-167.
22. Houslay MD, Adams DR. 2003. PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem J 370: 1-18.
23. Huston E, Lumb S, Russell A, Catterall C, Ross AH, Steele MR, Bolger GB, Perry MJ, Owens RJ, Houslay MD. 1997. Molecular cloning and transient expression in COS7 cells of a novel human PDE4B cAMP-specific phosphodiesterase, HSPDE4B3. Biochem J 328: 549-558.
24. Jin SL, Conti M. 2002. Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses. Proc Natl Acad Sci U S A 99: 7628-7633.
25. Jin SL, Lan L, Zoudilova M, Conti M. 2005. Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages. J Immunol 175: 1523-1531.
26. Johnson AK, Gross PM. 1993. Sensory circumventricular organs and brain homeostatic pathways. FASEB J 7: 678-686.
27. Khan NA, Khan A, Savelkoul HF, Benner R. 2002. Inhibition of septic shock in mice by an oligopeptide from the beta-chain of human chorionic gonadotrophin hormone. Hum Immunol 63: 1-7.
28. Kloss CU, Bohatschek M, Kreutzberg GW, Raivich G. 2001. Effect of lipopolysaccharide on the morphology and integrin immunoreactivity of ramified microglia in the mouse brain and in cell culture. Exp Neurol 168: 32-46.
29. Konsman JP, Parnet P, Dantzer R. 2002. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci 25: 154-159.
30. Laflamme N, Lacroix S, Rivest S. 1999. An essential role of interleukin-1beta in mediating NF-kappaB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia. J Neurosci 19: 10923-10930.
31. Lambertsen KL, Clausen BH, Babcock AA, Gregersen R, Fenger C, Nielsen HH, Haugaard LS, Wirenfeldt M, Nielsen M, Dagnaes-Hansen F, Bluethmann H, Faergeman NJ, Meldgaard M, Deierborg T, Finsen B. 2009. Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J Neurosci 29: 1319-1330.
32. Landry M, Holmberg K, Zhang X, Hokfelt T. 2000. Effect of axotomy on expression of NPY, galanin, and NPY Y1 and Y2 receptors in dorsal root ganglia and the superior cervical ganglion studied with double-labeling in situ hybridization and immunohistochemistry. Exp Neurol 162: 361-384.
33. Liberto CM, Albrecht PJ, Herx LM, Yong VW, Levison SW. 2004. Pro-regenerative properties of cytokine-activated astrocytes. J Neurochem 89: 1092-1100.
34. Miró X, Perez-Torres S, Palacios JM, Puigdomenech P, Mengod G. 2001. Differential distribution of cAMP-specific phosphodiesterase 7A mRNA in rat brain and peripheral organs. Synapse 40: 201-214.
35. Miró X, Perez-Torres S, Puigdomenech P, Palacios JM, Mengod G. 2002. Differential distribution of PDE4D splice variant mRNAs in rat brain suggests association with specific pathways and presynaptical localization. Synapse 45: 259-269.
36. Mori F, Perez-Torres S, De Caro R, Porzionato A, Macchi V, Beleta J, Gavalda A, Palacios JM, Mengod G. 2010. The human area postrema and other nuclei related to the emetic reflex express cAMP phosphodiesterases 4B and 4D. J Chem Neuroanat 40: 36-42.
37. Oger S, Mehats C, Dallot E, Ferre F, Leroy MJ. 2002. Interleukin-1beta induces phosphodiesterase 4B2 expression in human myometrial cells through a prostaglandin E2- and cyclic adenosine 3', 5'-monophosphate-dependent pathway. J Clin Endocrinol Metab 87: 5524-5531.
38. Park JH, Shin SH. 1996. Induction of IL-12 gene expression in the brain in septic shock. Biochem Biophys Res Commun 224: 391-396.
39. 3H]rolipram binding autoradiography. Comparison with monkey and rat brain. J Chem Neuroanat 20: 349-374.
40. Pompeiano M, Palacios JM, Mengod G. 1992. Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding. J Neurosci 12: 440-453.
41. Quan N, Whiteside M, Herkenham M. 1998a. Cyclooxygenase 2 mRNA expression in rat brain after peripheral injection of lipopolysaccharide. Brain Res 802: 189-197.
42. Quan N, Whiteside M, Herkenham M. 1998b. Time course and localization patterns of interleukin-1beta messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide. Neuroscience 83: 281-293.
43. Reyes-Irisarri E, Perez-Torres S, Mengod G. 2005. Neuronal expression of cAMP-specific phosphodiesterase 7b mRNA in the rat brain. Neuroscience 132: 1173-1185.
44. Reyes-Irisarri E, Sanchez AJ, Garcia-Merino JA, Mengod G. 2007. Selective induction of cAMP phosphodiesterase PDE4B2 expression in experimental autoimmune encephalomyelitis. J Neuropathol Exp Neurol 66: 923-931.
45. Reyes-Irisarri E, Perez-Torres S, Miro X, Martinez E, Puigdomenech P, Palacios JM, Mengod G. 2008. Differential distribution of PDE4B splice variant mRNAs in rat brain and the effects of systemic administration of LPS in their expression. Synapse 62: 74-79.
46. Schiltz JC, Sawchenko PE. 2002. Distinct brain vascular cell types manifest inducible cyclooxygenase expression as a function of the strength and nature of immune insults. J Neurosci 22: 5606-5618.
47. Schmitz GG, Walter T, Seibl R, Kessler C. 1991. Nonradioactive labeling of oligonucleotides in vitro with the hapten digoxigenin by tailing with terminal transferase. Anal Biochem 192: 222-231.
48. Semmler A, Okulla T, Sastre M, Dumitrescu-Ozimek L, Heneka MT. 2005. Systemic inflammation induces apoptosis with variable vulnerability of different brain regions. J Chem Neuroanat 30: 144-157.
49. Serrats J, Artigas F, Mengod G, Cortes R. 2003. GABAB receptor mRNA in the raphe nuclei: co-expression with serotonin transporter and glutamic acid decarboxylase. J Neurochem 84: 743-752.
50. Sly LM, Krzesicki RF, Brashler JR, Buhl AE, McKinley DD, Carter DB, Chin JE. 2001. Endogenous brain cytokine mRNA and inflammatory responses to lipopolysaccharide are elevated in the Tg2576 transgenic mouse model of Alzheimer's disease. Brain Res Bull 56: 581-588.
51. Swinnen JV, Joseph DR, Conti M. 1989. The mRNA encoding a high-affinity cAMP phosphodiesterase is regulated by hormones and cAMP. Proc Natl Acad Sci U S A 86: 8197-8201.
52. Takahashi M, Terwilliger R, Lane C, Mezes PS, Conti M, Duman RS. 1999. Chronic antidepressant administration increases the expression of cAMP-specific phosphodiesterase 4A and 4B isoforms. J Neurosci 19: 610-618.
53. Tomiyama M, Palacios JM, Cortes R, Vilaro MT, Mengod G. 1997. Distribution of AMPA receptor subunit mRNAs in the human basal ganglia: an in situ hybridization study. Brain Res Mol Brain Res 46: 281-289.
54. Torphy TJ. 1998. Phosphodiesterase isozymes-molecular targets for novel antiasthma agents. Am J Respir Crit Care Med 157: 351-370.
55. Villa P, Ghezzi P. 2004. Animal models of endotoxic shock. Methods Mol Med 98: 199-206.
56. Yamamoto S, Sugahara S, Ikeda K, Shimizu Y. 2006. Pharmacological profile of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on acute and chronic inflammation models. Eur J Pharmacol 550: 166-172.